Covid-19 and the health of people who use drugs
What is and what could be
Datos Bibliográficos
| ID | 14908136 |
|---|---|
| Autores | J Grebely (0000-0002-1833-2017, UNSW Sydney, autor de correspondencia), Magdalena Cerdá (0000-0001-8441-7046, New York University), Tammy Rhodes (0000-0003-2400-9838, London School of Hygiene & Tropical Medicine) |
| Año | 2020 |
| Volumen | 83 |
| Páginas | 102958 |
| Fecha de publicación | 2020-09-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2020.102958 |
| PMID | 33183679 |
| OpenAlex | W3106187707 |
| Idioma | EN |
| Citas recibidas | 52 |
| Referencias citadas | 122 |
Adaptation (eye · Affect (linguistics · Business · Coronavirus disease 2019 (COVID-19 · Disease · Economics · Ethos · Political science · Psychiatry · Psychological intervention · Public economics · Public relations · SAFER · Social distance · COVID-19 Clinical Research Studies · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Psychology
Covid-19 and people who use drugs; seizing opportunity in times of chaos
Trends in deaths following drug use in England before, during, and after the Covid-19 lockdowns
Digital Interventions to Save Lives From the Opioid Crisis Prior and During the Sars Covid-19 Pandemic
Covid-19 and child criminal exploitation in the UK
Navigating the Covid-19 Risk Environment, Overdose Prevention, and Self Care Practices of People Who Use Illicit Opioids in New York City
Risk environments of people who use drugs during the Covid-19 pandemic – the view of social workers and health care professionals in Sweden
Adapting to changing risk environments
User perspectives on outreach opioid substitution treatment among street-entrenched people who use drugs in Denmark
Closing doors, opening windows – Adaptations and opportunities for harm reduction services during the Covid-19 pandemic in Europe
Implementing drug checking as an illicit drug market intervention within the supply chain in a Canadian setting
People engaged in opioid agonist treatment as a counterpublic during the Covid ‐19 pandemic in Australia
‘Super googs on a Zoom, are you kidding me?’
Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia
The Impact of Covid-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals
At the Intersection of Harm Reduction and Covid-19
“Do you deny somebody Suboxone … if they just didn’t pee in a cup for you?”
Covid-19 Impact on Healthcare and Supportive Services for People Who Use Drugs (PWUDs) in Malaysia
Reducing Problematic Substance Use under Exceptional Circumstances—Effects of the Covid-19 Restrictions on Inpatient Substance Use Disorder Treatment in Finland
It’s just a perfect storm”
The impact of Covid-19 on access to harm reduction, substance use treatment and recovery services in Scotland
Spotting as a risk mitigation method
Covid-19 economic impact payments and opioid overdose deaths
Impact of Covid-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Change creates change’ – older female sex workers’ experiences through the early Covid-19 pandemic
Covid-19 economic impact payments and opioid overdose deaths
Living Under Coronavirus and Injecting Drugs in Bristol (Lucid-B)
Futures-oriented drugs policy research
General hospital admissions in young and middle-aged people who use psychoactive substances
HIV and HCV seroincidence, associated factors and drug use in people who inject drugs, SurvUDI network, eastern central Canada, 1995–2020
Drug treatment and support service utilization amidst the Covid-19 pandemic among people who inject drugs in Baltimore, Maryland
Pathways between Covid-19 public health responses and increasing overdose risks
Increased solitary drug use during Covid-19
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
The Covid-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during Covid-19 and the ongoing overdose emergency
Spatial and neighborhood-level correlates of lay naloxone reversal events and service availability
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the Covid-19 pandemic in England
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Volatile drug use and overdose during the first year of the Covid-19 pandemic in the United States
Telemedicine and decentralized hepatitis C treatment as a strategy to enhance retention in care among people attending drug treatment centres
You'll come in and dose even in a global pandemic”
What's in Stock? Drug drought anticipation during Covid-19 among people who use drugs and service providers
Maintaining HIV and HCV prevention and care for people who inject drugs despite Covid‐19 in Hai Phong, Vietnam”
Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the Covid-19 pandemic
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada
Political partisanship and stigma against people who use drugs in opinions about allocating Covid-19 prevention resources to vulnerable populations
The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence
Established Tables and Emergent Huddles
More Concerned About Mr. and Mrs. Denmark”
Precarious Lives, Precarious Treatments
Psychosocial experience of the Covid-19 crisis among people who use or inject drugs in Algeria
Meta‐analysis of drug‐related deaths soon after release from prison
Challenges posed by Covid‐19 to people who inject drugs and lessons from other outbreaks
A systematic review of injecting-related injury and disease among people who inject drugs
Studying complexity in health services research
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
War on Drugs Policing and Police Brutality
Covid-19
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With Covid-19 in the New York City Area
Mitigating the wider health effects of covid-19 pandemic response
Challenges in maintaining treatment services for people who use drugs during the Covid-19 pandemic
Global patterns of opioid use and dependence
How Do We Balance Tensions Between Covid-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research
Stigma, social inequality and alcohol and drug use
The need for a complex systems model of evidence for public health
Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons
Responding to global stimulant use
HIV infection associated with drug injecting in the Newly Independent States, eastern Europe
Towards a general theory of implementation
Stigma during the Covid-19 pandemic
Signal of increased opioid overdose during Covid-19 from emergency medical services data
An interactive web-based dashboard to track Covid-19 in real time
Mental Health and the Covid-19 Pandemic
Modelling the pandemic
Patterns of Polysubstance Use among Adults with Tranquilizer Misuse
Illicit drug use and harms in Australia in the context of Covid ‐19 and associated restrictions
The hidden vulnerability of homelessness in the Covid-19 pandemic
Whose responsibility? Covid‐19 in a homeless shelter in the UK
Crack and the Political Economy of Social Suffering
Towards a theory of drug use contexts
Internalized HIV and Drug Stigmas
You are not clean until you're not on anything”
Why we should all be more careful in drawing conclusions about how Covid-19 is changing drug markets
Economic recession, drug use and public health
Covid-19 - Enacting a ‘new normal’ for people who use drugs
Syringe services program (SSP) operational changes during the Covid-19 global outbreak
Continuing increased access to buprenorphine in the United States via telemedicine after Covid-19
The perfect storm
Eradication in the time of Covid
Rural risk environments, opioid-related overdose, and infectious diseases
An examination of injection drug use trends in Victoria and Vancouver, BC after the closure of Victoria's only fixed-site needle and syringe programme
Stigma at every turn
The ‘risk environment’
Safer opioid distribution in response to the Covid-19 pandemic
The impact of Covid-19 restrictions on needle and syringe programme provision and coverage in England
Challenges of providing Covid-19 prevention services to homeless people who use drugs in Iran
Racialized risk environments in a large sample of people who inject drugs in the United States
Isolating the isolated
Today’s fentanyl crisis
Drug use during a pandemic
Substance use and recessions
Theorizing “Big Events” as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks
Care during Covid-19
The chronotope of the queue
No “back to normal” after Covid-19 for our failed drug policies
An urgent impetus for action
Safe and unsafe spaces
No magic pocket
Preliminary findings of the impact of Covid-19 on drugs crypto markets
The triple wave epidemic
The social life of drugs
The Sars-Cov-2 threat in Cracolândia, an open-air drug use scene in Brazil
Addressing co-occurring public health emergencies
Illegal drug use and the economic recession—What can we learn from the existing research
The consequences of perceived discrimination for psychological well-being
Making evidence and policy in public health emergencies
A Community Responds to the Covid-19 Pandemic
Proximal, Distal, and the Politics of Causation
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization
Assemblages of Health
Risk environments and drug harms
The intersectional risk environment of people who use drugs
Hospitals as a 'risk environment
Evidence-making interventions in health
Thinking about changing mobility practices
| Obras citantes distintas | 52 |
|---|---|
| Citas por año | 10,4 |
| Intervalo de citas | 2021 - 2025 (5) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 51 |